-
Uncategorized1 month ago
Tackling drug resistance must become biotech’s next frontier
Tackling drug resistance must become biotech’s next frontier
-
Uncategorized1 month ago
FDA’s end to 9-month adcomm drought a ‘narrow restart’
While some analysts consider the return of advisory committees a positive sign for the FDA—and the biopharma industry more widely—others are keeping their optimism in check,...
-
Uncategorized1 month ago
Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
Avalyn Pharma has overshot its expectations with a $300 million IPO that the biotech will use to fund late-stage studies of its inhaled versions of approved...
-
Uncategorized1 month ago
AstraZeneca plucks preclinical EGFR degrader from Pinetree for $25M
AstraZeneca has paid $25 million to pick up a preclinical EGFR degrader that was at the center of its existing pact with Pinetree Therapeutics.Read More
-
Uncategorized1 month agoAvalyn, in pursuit of better lung drugs, banks $300M in an IPO
The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the “idiopathic” and “progressive” forms of pulmonary fibrosis. Read...
-
Uncategorized1 month ago
Restoring Vision with Stem Cell–Derived Retinal Cells by Overcoming ILM Barrier
Degeneration of retinal ganglion cells can cause irreversible vision loss. Pluripotent stem cells (PSCs) could, in theory, be used to replace lost ganglion cells. However, past...
-
Uncategorized1 month agoHHS appeals ruling that stalled many of Kennedy’s vaccine policy changes
The Department of Justice is appealing a ruling by a federal judge which stalled many of health secretary Robert F. Kennedy Jr.’s changes to federal vaccine...
-
Uncategorized1 month ago
STRAIGHT-IN Dual: a platform for dual single-copy integrations of DNA payloads and gene circuits into human induced pluripotent stem cells
Post Content
-
Uncategorized1 month ago
Tracing the rise of biomedical foundation models
Nature Biotechnology, Published online: 30 April 2026; doi:10.1038/s41587-026-03135-y A survey of biological foundation models reveals current trends and provides an outlook for future developments in this...
-
Uncategorized1 month agoSTAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
After months of anticipation, Supreme Court justices heard arguments about a long-standing tactic used by generic companies to carve out a distinct market for a medicine,...
